Print

HVTN 124

Trial Details:

I Ongoing
National Institute of Allergy and Infectious Diseases (NIAID) March 16, 2018
env (A,B,C,A/E)/gag (C) DNA Vaccine,gp120 (A,B,C,A/E) Protein Vaccine ?env (A,B,C,A/E)/gag (C) DNA Vaccine?; ?gp120 (A,B,C,A/E) Protein Vaccine
env (A,B,C,A/E)/gag (C) DNA Vaccine DNA
gp120 (A,B,C,A/E) Protein Vaccine Protein
GLA-SE
USA 60
NCT03409276
https://clinicaltrials.gov/ct2/show/NCT03409276